MAPT and Alzheimer disease: The event leveraged a dataset accessible via AD Workbench, the collaborative workspaces, and pre‐configured analysis tools to interrogate how the amyloid, tau, and neurodegeneration (ATN) criteria are associated with various profiles in high‐risk individuals.